We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
β -Amylase (EC 3.2.1.2) is an exotype glycosylase. When acting on starch, cut a maltose unit from the non-reducing end of the α -1-4 glycoside bond, to produce maltose and macromolecular β -limit dextrin. Since the enzyme acts on the substrate, Walden inverts to change the product from α-maltose to β-maltose. β -Amylase cannot hydrolyze the α -1,6 bond of amylopectin, nor continue to hydrolysis across the branch point, therefore, the hydrolysis of amylopectin is incomplete, with the β -limit dextrin of residual macromolecules. When β -amylase hydrolyzes starch, because there are always macromolecules from the end of the molecule, the viscosity decline is very slow and cannot be used as a liquefied enzyme, while β -amylase hydrolyzes starch hydrolysis products such as maltodextrin and maltooligosaccharide, the hydrolysis speed is very fast, so it is used as a saccharification enzyme.
Fig.1 Mode action of the β-amylase. (CD BioGlyco)
Modified starches display improved paste clarity, paste and gel texture, film formation, and adhesiveness as well as decreased retrogradation, gelling tendencies of pastes, and gel syneresis. CD BioGlyco uses β-amylase to improve the characteristics of corn starch.
Fig.2 Technology roadmap of corn-modified starch. (CD BioGlyco, 2023)
Based on our One-Stop Solution for Carbohydrate Manufacture platform, CD BioGlyco not only provides Polysaccharide Manufacture Services but also Monosaccharide, Oligosaccharide, Glycolipid, etc. Moreover, we have several Technologies for Modified Starch Manufacture, using physical, chemical enzymatic, and genetic modification methods. If you have any needs in glycobiology, please feel free to .
References
Seamlessly acquired the top-notch and customized carbohydrate manufacture services you seek.